Cannara Biotech Inc.
LOVE.TO
TSX
| 05/31/2026 | 02/28/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 14.03% | -7.61% | |||
| Total Other Revenue | 1,505.79% | 1.26% | |||
| Total Revenue | 15.84% | -7.60% | |||
| Cost of Revenue | 6.98% | -15.89% | |||
| Gross Profit | 27.66% | 6.38% | |||
| SG&A Expenses | -7.62% | -2.26% | |||
| Depreciation & Amortization | -6.79% | -2.93% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.80% | -11.19% | |||
| Operating Income | 114.00% | 28.87% | |||
| Income Before Tax | 141.10% | 41.45% | |||
| Income Tax Expenses | 73.56% | 18.30% | |||
| Earnings from Continuing Operations | 188.13% | 63.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 188.13% | 63.74% | |||
| EBIT | 114.00% | 28.87% | |||
| EBITDA | 90.22% | 12.76% | |||
| EPS Basic | 180.31% | 60.76% | |||
| Normalized Basic EPS | 125.00% | 42.86% | |||
| EPS Diluted | 180.31% | 76.39% | |||
| Normalized Diluted EPS | 126.28% | 44.21% | |||
| Average Basic Shares Outstanding | 2.52% | 2.82% | |||
| Average Diluted Shares Outstanding | 2.13% | 2.33% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||